Nirlon Limited (BOM:500307)

Sage Therapeutics Revenue

In the fiscal year ending March 31, 2025, Nirlon had annual revenue of 6.36B INR with 5.46% growth. Nirlon had revenue of 1.58B in the quarter ending March 31, 2025, with 3.04% growth.

• Revenue: 6.36B
• Revenue Growth: +5.46%
• P/S Ratio: 7.51
• Revenue / Employee: 2.12B
• Employees: 3
• Market Cap: 47.77B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.36B	329.55M	5.46%
Mar 31, 2024	6.03B	304.72M	5.32%
Mar 31, 2023	5.73B	1.89B	49.15%
Mar 31, 2022	3.84B	670.32M	21.15%
Mar 31, 2021	3.17B	69.12M	2.23%